China SXT Pharmaceuticals, Inc. (SXTC) KPIs and segments
Close on Nov 13, 2026Market cap $2.87MP/E –Yield –
KPIs & segments
Operating metrics and segments that drive China SXT Pharmaceuticals's business
China SXT Pharmaceuticals's revenue by segment, product and region, plus the counts and sizes it tags in its 10-K and 10-Q filings (XBRL). Each figure links to the filing it came from. A fuller KPI sheet built from earnings releases and presentations is on the way. See the segment tables for a trailing-twelve-month view, or how companies compare on operating metrics.
The chart is empty. Tick the box next to any metric in the table below to plot it — tick several to compare them on one chart.
China SXT Pharmaceuticals's fiscal year ends March 31 — FY2026 = CY2025 (calendar year).
| Add to chart | Metric | FY2026 CY2025 | FY2025 CY2024 | FY2024 CY2023 | FY2023 CY2022 | FY2022 CY2021 |
|---|---|---|---|---|---|---|
Revenues generated from third parties($M) | 1.14 | 1.74 | 1.90 | 1.94 | 2.26 | |
Regular TCMP($M) | 1.08 | 1.44 | ||||
Advanced TCMP($M) | 0.05 | 0.26 | ||||
Others($M) | 0.01 | 0.04 | ||||
Revenue generated from related parties($M) | 0 | 0.00 | 0.03 | 0.03 | 0.34 | |
Italic numbers are calculated by StockData from reported figures (hover for the formula). Numbers with a dotted underline are read from the text of earnings releases and presentations; hover to see the exact sentence. Tick a row to add it to the chart above (up to 8 lines).
Methodology and excluded metrics
- Core rows come from the segment and revenue-disaggregation notes of 10-K and 10-Q filings (XBRL), linked to each filing. Fourth-quarter figures are the fiscal year less the first nine months (shown in italic).
Data updated 2026-07-01.
See a number that looks wrong?